Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000793

Drug Information
SynonymsEthanamine, 2-(4-((1Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-; BIDD:ER0222; 2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine; NCGC00160530-01; CHEMBL1655; C08166; D08620; 98644-21-4; BIDD:GT0211; CHEBI:9635; GTx-006; STK626445; (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine; Z-Toremifene; 89778-27-8 (citrate (1:1)); Toremifene Citrate (1:1); GTx 006; {2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine; CCRIS 8745; Farestone; 2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine; toremifene; Ethanamine, 2-(4-(4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-; CID3005573; GTX-006 (Acapodene); Toremifeno; 2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1); Toremifeno [Spanish]; AC-1751; Estrimex; STOCK6S-27411; DB00539; FC-1157a; HMS2090B22; Toremifenum; 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine; UNII-7NFE54O27T; AC1MHJ33; 89778-26-7; 2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC); LS-7729; Toremifenum [Latin]; MolPort-002-508-208; BIDD:PXR0202; Acapodene; Toremifene Base; Toremifene [INN:BAN]; Toremifene (INN)
Trade NameFareston; Acapodene
CompanyGTx, Inc
IndicationBreast CancerApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3    
Isomeric SMILESCN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3
Therapeutic ClassAntineoplastic Agents
CAS NumberCAS 89778-26-7
PubChem Compound IDCID 3005573.
PubChem Substance IDSID 10366.
SuperDrug ATC IDL02BA02
SuperDrug CAS ID089778267;
TargetEstrogen receptorModulator[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Effect of selective estrogen receptor modulators on cell proliferation and estrogen receptor activities in normal human prostate stromal and epithelial cells. Prostate Cancer Prostatic Dis. 2009 May 26. [Epub ahead of print] To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543